BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31274411)

  • 21. Barriers and Facilitators of HPV Vaccination in the VFC Program.
    Fleming WS; Sznajder KK; Nepps M; Boktor SW
    J Community Health; 2018 Jun; 43(3):448-454. PubMed ID: 29299729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
    Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
    Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    Topazian HM; Kundu D; Peebles K; Ramos S; Morgan K; Kim CJ; Richter KL; Brewer NT; Peris M; Smith JS
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):575-582.e2. PubMed ID: 30017958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives.
    Yared N; Malone M; Welo E; Mohammed I; Groene E; Flory M; Basta NE; Horvath KJ; Kulasingam S
    Cancer Causes Control; 2021 Oct; 32(10):1107-1116. PubMed ID: 34247291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers' perspectives.
    Vu M; King AR; Jang HM; Bednarczyk RA
    Health Educ Res; 2020 Dec; 35(6):512-523. PubMed ID: 32879948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical and public health professionals' perceived facilitators and barriers of human papillomavirus (HPV) vaccination among African American adolescents in Shelby County, Tennessee.
    Jin SW; Lattimore DC; Harlin E; Davis L; Erholtz V; Brandt HM
    BMC Health Serv Res; 2023 May; 23(1):469. PubMed ID: 37165427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action.
    Cartmell KB; Young-Pierce J; McGue S; Alberg AJ; Luque JS; Zubizarreta M; Brandt HM
    Papillomavirus Res; 2018 Jun; 5():21-31. PubMed ID: 29248818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitators and barriers of healthcare workers' recommendation of HPV vaccine for adolescents in Nigeria: views through the lens of theoretical domains framework.
    Balogun FM; Omotade OO
    BMC Health Serv Res; 2022 Jun; 22(1):824. PubMed ID: 35752809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers.
    Katz IT; Bogart LM; Fu CM; Liu Y; Cox JE; Samuels RC; Chase T; Schubert P; Schuster MA
    BMC Public Health; 2016 Aug; 16(1):874. PubMed ID: 27558506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a human papillomavirus vaccination training implementation in clinical and community settings across different clinical roles.
    Maynard G; Akpan IN; Meadows RJ; Fulda KG; Patel DA; Leidner V; Taskin T; Gehr AW; Lu Y; Matches S; Thompson EL
    Transl Behav Med; 2024 Mar; 14(4):249-256. PubMed ID: 38459904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).
    Bocquier A; Bruel S; Michel M; Le Duc-Banaszuk AS; Bonnay S; Branchereau M; Chevreul K; Chyderiotis S; Gauchet A; Giraudeau B; Hagiu DP; Mueller JE; Gagneux-Brunon A; Thilly N;
    Health Expect; 2023 Oct; 26(5):1843-1853. PubMed ID: 37312280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.
    Holman DM; Benard V; Roland KB; Watson M; Liddon N; Stokley S
    JAMA Pediatr; 2014 Jan; 168(1):76-82. PubMed ID: 24276343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
    Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
    JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining the Barriers and Opportunities for Human Papillomavirus Vaccine Delivery in Cancer Care Settings: A Mixed-Methods Study.
    Garcia MA; Schlecht NF; Rokitka DA; Attwood KM; Rodriguez EM
    Cancer Prev Res (Phila); 2023 Oct; 16(10):581-589. PubMed ID: 37258419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study.
    Rubens-Augustson T; Wilson LA; Murphy MS; Jardine C; Pottie K; Hui C; Stafström M; Wilson K
    Hum Vaccin Immunother; 2019; 15(7-8):1697-1707. PubMed ID: 30352005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.
    Cheruvu VK; Bhatta MP; Drinkard LN
    BMC Pediatr; 2017 Feb; 17(1):52. PubMed ID: 28193249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parent-Level Barriers and Facilitators to HPV Vaccine Implementation in Santo Domingo, Dominican Republic.
    Liebermann E; Devanter NV; Frías Gúzman N; Ompad D; Shirazian T; Healton C
    J Community Health; 2020 Oct; 45(5):1061-1066. PubMed ID: 32394119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary care team- and clinic level factors affecting HPV vaccine uptake.
    Chuang E; Cabrera C; Mak S; Glenn B; Hochman M; Bastani R
    Vaccine; 2017 Aug; 35(35 Pt B):4540-4547. PubMed ID: 28736202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local Health Department Interest in Implementation of a Jail-Based Human Papillomavirus Vaccination Program in Kansas, Iowa, Missouri, and Nebraska.
    Ramaswamy M; Allison M; Musser B; Satterwhite C; Armstrong R; Kelly PJ
    J Public Health Manag Pract; 2020; 26(2):168-175. PubMed ID: 31313718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.